Cathrine L. Denton

Comparative analysis of MAPK and PI3K/AKT pathway activation and inhibition in human and canine melanoma

Jared S. Fowles, Cathrine L. Denton, Daniel L. Gustafson · Veterinary and Comparative Oncology · 2013 · 77 citations

Medicine, Oncology, Pharmacology +17

Pharmacokinetics and pharmacodynamics of AZD6244 (ARRY-142886) in tumor-bearing nude mice

Cathrine L. Denton, Daniel L. Gustafson · Cancer Chemotherapy and Pharmacology · 2010 · 49 citations

Medicine, Pharmacokinetics, Pharmacology +12

Pharmacology of DB844, an Orally Active aza Analogue of Pafuramidine, in a Monkey Model of Second Stage Human African Trypanosomiasis

John K. Thuita, Michael Z. Wang, John Kagira et al. · PLoS neglected tropical diseases · 2012 · 40 citations · Full text

Medicine, Infectious Diseases, Pharmacology +15

Analysis of HIV-1 subtype B third variable region peptide motifs for induction of neutralizing antibodies against HIV-1 primary isolates

Barton F. Haynes, Benjiang Ma, David C. Montefiori et al. · Virology · 2005 · 38 citations

Pharmacy, Infectious Diseases, Molecular Biology +12

Concomitant Oral and Intravenous Pharmacokinetics of Dabrafenib, a BRAF Inhibitor, in Patients with BRAF V600 Mutation‐Positive Solid Tumors

Cathrine L. Denton, Elisabeth A. Minthorn, Stanley W. Carson et al. · The Journal of Clinical Pharmacology · 2013 · 38 citations

Pharmacy, Pharmacokinetics, Pharmacology +13